Virologically suppressed patients with asymptomatic and symptomatic HIV‐associated neurocognitive disorders do not display the same pattern of immune activation

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1293|16|7|431-440

ISSN： 1464-2662

Source： HIV MEDICINE, Vol.16, Iss.7, 2015-08, pp. : 431-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune activation in leishmania/HIV‐1 coinfection

By  

HIV MEDICINE, Vol. 16, Iss. 4, 2015-04 ,pp. : 240-248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cocaine and HIV‐1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV‐associated neurocognitive disorders in cocaine user patients

By  

GLIA, Vol. 66, Iss. 4, 2018-04 ,pp. : 889-902

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD4 count monitoring seldom contributes to clinical‐decision making

By  

HIV MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 196-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders

By Liu Han   Xu Enquan   Liu Jianuo   Xiong Huangui  

Brain Sciences, Vol. 6, Iss. 3, 2016-07 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 497-502

John Wiley & Sons Inc

Access to resources Recommend Favorite